|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-jRCTs041180018 |
|
Date of registration:
|
20/12/2018 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Pupillary autonomic dysfunction and visual hallucination in Parkinson's disease
|
|
Scientific title:
|
Association between pupillary autonomic dysfunction and visual
hallucination in Parkinson's disease - Pupillary autonomic dysfunction and visual hallucination in Parkinson's disease |
|
Date of first enrolment:
|
04/09/2017 |
|
Target sample size:
|
40 |
|
Recruitment status: |
Complete |
|
URL:
|
https://jrct.niph.go.jp/latest-detail/jRCTs041180018 |
|
Study type:
|
Interventional |
|
Study design:
|
single arm study, open(masking not used), no treatment control/standard of care control, single assignment, diagnostic purpose
|
|
Phase:
|
2
|
|
|
Contacts
|
|
Name:
|
Masahisa
katsuno |
|
Address:
|
65 Tsurumai-cho, Showa-ku, Nagoya
466-8560
Aichi
Japan |
|
Telephone:
|
+81-52-744-2391 |
|
Email:
|
ka2no@med.nagoya-u.ac.jp |
|
Affiliation:
|
Nagoya University Graduate School of Medicine |
|
|
Name:
|
Tomohiko
Nakamura |
|
Address:
|
65 Tsurumai-cho, Showa-ku, Nagoya
466-8560
Aichi
Japan |
|
Telephone:
|
+81-52-744-2604 |
|
Email:
|
tomohiko@med.nagoya-u.ac.jp |
|
Affiliation:
|
Nagoya University Hospital |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria: Parkinson disease and related diseases
Exclusion criteria: Pupillary autonomic neuropathy
Age minimum:
>= 40age old
Age maximum:
Not applicable
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Parkinson's disease and related diseases
|
|
Intervention(s)
|
|
Two drops of 0.05% pilocarpine hydrochloride, which is a parasympathomimetic agent, on the right eye, 2 drops of 0.04% dipivefrin hydrochloride, which is a sympathomimetic agent, to the left eye
|
|
Primary Outcome(s)
|
|
Correlation between pupil autonomic function and hallucination
|
|
Secondary Outcome(s)
|
|
Correlation between pupil autonomic function and cognitive function, and UPDRS
|
|
Secondary ID(s)
|
|
UMIN000026128
|
|
Source(s) of Monetary Support
|
|
Ethics review
|
Status: Approval
Approval date:
Contact:
ethics@med.nagoya-u.ac.jp
Nagoya University Clinical Research Review Board
+81-52-744-2479
ethics@med.nagoya-u.ac.jp
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
15/02/2021 |
|
Date Completed:
|
08/01/2020 |
|
URL:
|
|
|
|